Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:317-323
Published online before print July 12, 2004, doi: 10.1161/01.CIR.0000135599.33787.CA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/3/317    most recent
01.CIR.0000135599.33787.CAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mano, A.
Right arrow Articles by Matsubara, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mano, A.
Right arrow Articles by Matsubara, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Congestive
Right arrow ACE/Angiotension receptors
Right arrow Apoptosis

(Circulation. 2004;110:317-323.)
© 2004 American Heart Association, Inc.


Original Articles

Aldosterone Directly Induces Myocyte Apoptosis Through Calcineurin-Dependent Pathways

Akiko Mano, MD; Tetsuya Tatsumi, MD, PhD; Jun Shiraishi, MD, PhD; Natsuya Keira, MD, PhD; Tetsuya Nomura, MD; Mitsuo Takeda, MD; Susumu Nishikawa, MD; Satoshi Yamanaka, MD, PhD; Satoaki Matoba, MD, PhD; Miyuki Kobara, MD, PhD; Hideo Tanaka, MD, PhD; Takeshi Shirayama, MD, PhD; Tetsuo Takamatsu, MD, PhD; Yoshihisa Nozawa, PhD; Hiroaki Matsubara, MD, PhD

From the Departments of Cardiovascular Medicine and Pathology and Cell Regulation (H.T., T.T.), Kyoto Prefectural University School of Medicine, Kyoto, and Pharmacobioregulation Research Laboratory (Y.N.), Taiho Pharmaceutical Co. Ltd, Iinou, Japan.

Correspondence to Tetsuya Tatsumi, MD, PhD, Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. E-mail tatsumi{at}koto.kpu-m.ac.jp

Received January 21, 2004; revision received April 1, 2004; accepted April 5, 2004.

Background— Aldosterone has recently attracted considerable attention for its involvement in the pathophysiology of heart failure, in which apoptotic cell loss plays a critical role. This study examined whether aldosterone directly induces myocyte apoptosis via its specific receptors.

Methods and Results— Neonatal rat cardiac myocytes were exposed to aldosterone (10–8 to 10–5 mol/L). Nuclear staining with Hoechst 33258 showed that aldosterone induced myocyte apoptosis in a dose- and time-dependent fashion. Treatment of myocytes with 10–5 mol/L aldosterone significantly increased the percentage of apoptosis (15.5±1.4%) compared with serum-deprived control (7.3±0.6%). Radio ligand binding assay revealed the existence of plasma membrane receptor with high affinity (Kd, 0.2 nmol/L) for aldosterone in cardiac myocytes but not in fibroblasts. Aldosterone rapidly ({approx}30 seconds) mobilized [Ca2+]i that was blocked by neomycin. Aldosterone induced dephosphorylation of the proapoptotic protein Bad, enhancement of mitochondrial permeability transition, decrease in mitochondrial membrane potential, and release of cytochrome c from the mitochondria into the cytosol with concomitant activation of caspase-3. These effects of aldosterone were inhibited by concurrent treatment with either an L-type Ca2+ channel antagonist, nifedipine, or inhibitors for the Ca2+-dependent phosphatase calcineurin, cyclosporin A and FK506.

Conclusions— The present study demonstrates for the first time that the specific plasma membrane receptor (coupled with phospholipase C) for aldosterone is present on cardiac myocytes and that aldosterone accelerates the mitochondrial apoptotic pathway through activation of calcineurin and dephosphorylation of Bad, suggesting that the proapoptotic action of aldosterone may directly contribute to the progression of heart failure.


Key Words: angiotensin • apoptosis • heart failure




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. S. De Silva, R. M. Wilson, C. Hutchinson, P. C. Ip, A. G. Garcia, S. Lancel, M. Ito, D. R. Pimentel, and F. Sam
Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1983 - H1993.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W.-Q. Tan, J.-X. Wang, Z.-Q. Lin, Y.-R. Li, Y. Lin, and P.-F. Li
Novel Cardiac Apoptotic Pathway: The Dephosphorylation of Apoptosis Repressor With Caspase Recruitment Domain by Calcineurin
Circulation, November 25, 2008; 118(22): 2268 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. T. Mathew, H. Patni, A. N. Chaudhary, W. Liang, A. Gupta, P. N. Chander, G. Ding, and P. C. Singhal
Aldosterone induces mesangial cell apoptosis both in vivo and in vitro
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F73 - F81.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Iwazu, S. Muto, G. Fujisawa, E. Nakazawa, K. Okada, S. Ishibashi, and E. Kusano
Spironolactone Suppresses Peritubular Capillary Loss and Prevents Deoxycorticosterone Acetate/Salt-Induced Tubulointerstitial Fibrosis
Hypertension, March 1, 2008; 51(3): 749 - 754.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Colella, F. Grisan, V. Robert, J. D. Turner, A. P. Thomas, and T. Pozzan
Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: Role of calcineurin/NFAT as Ca2+ signal integrators
PNAS, February 26, 2008; 105(8): 2859 - 2864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Patni, J. T. Mathew, L. Luan, N. Franki, P. N. Chander, and P. C. Singhal
Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1065 - F1071.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Q. Liu, B. J. Wilkins, Y. J. Lee, H. Ichijo, and J. D. Molkentin
Direct Interaction and Reciprocal Regulation between ASK1 and Calcineurin-NFAT Control Cardiomyocyte Death and Growth
Mol. Cell. Biol., May 15, 2006; 26(10): 3785 - 3797.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Yamamuro, M. Yoshimura, M. Nakayama, K. Abe, M. Shono, S. Suzuki, T. Sakamoto, Y. Saito, K. Nakao, H. Yasue, et al.
Direct Effects of Aldosterone on Cardiomyocytes in the Presence of Normal and Elevated Extracellular Sodium
Endocrinology, March 1, 2006; 147(3): 1314 - 1321.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. K. Rude, T.-A. S. Duhaney, G. M. Kuster, S. Judge, J. Heo, W. S. Colucci, D. A. Siwik, and F. Sam
Aldosterone Stimulates Matrix Metalloproteinases and Reactive Oxygen Species in Adult Rat Ventricular Cardiomyocytes
Hypertension, September 1, 2005; 46(3): 555 - 561.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. S. Mihailidou
Nongenomic Cardiovascular Actions of Aldosterone: A Receptor for All Seasons?
Endocrinology, March 1, 2005; 146(3): 971 - 972.
[Full Text] [PDF]